New Study Affirms Mesothelioma Survival Benefit with Post-Surgical IMRT, According to Surviving Mesothelioma

Share Article

Texas researchers say targeted radiotherapy can improve outcomes after radical mesothelioma surgery.

Mesothelioma Surviving Improves with IMRT

IMRT After Mesothelioma Surgery: Survival Benefit?

...relapse-free survival and overall survival comparable to the published literature without significant toxicity.

Scientists in Austin and Temple, Texas say mesothelioma patients who undergo hemithoracic (one-sided) intensity modulated radiotherapy after extrapleural pneumonectomy live longer than those who do not have the treatment, Surviving Mesothelioma has just published an article on the new findings. Click here to read it now.

Doctors at Austin Cancer Centers and Baylor Scott and White Health performed a retrospective analysis of 18 pleural mesothelioma patients who had lung-removing EPP surgery followed by IMRT between 2005 and 2014.

Lead researcher and radiation oncologist Sameer Jhavar, MD, PhD, concludes, “Intensity-modulated radiation therapy following EPP for malignant pleural mesothelioma resulted in relapse-free survival and overall survival comparable to the published literature without significant toxicity.”

According to the report in the Asia-Pacific Journal of Clinical Oncology, 44 percent of mesothelioma patients in the study were still alive three years after treatment.

“Although this is a small study, the survival results are a hopeful sign for patients considering radical mesothelioma surgery,” says Alex Strauss, Managing Editor for Surviving Mesothelioma.

To read more about the new Texas study and other recent IMRT research in mesothelioma treatment, see New Evidence Supports Post-Surgical IMRT for Mesothelioma Treatment, now available on the Surviving Mesothelioma website.

Jhavar, S, “Intensity modulated radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma is feasible without fatal pulmonary toxicity and provides good survival,” Asia-Pacific Journal of Clinical Oncology, March 29, 2017, Epub ahead of print, https://www.ncbi.nlm.nih.gov/pubmed/28371288

For more than a decade, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Michael Ellis
Cancer Monthy
+1 (919) 570-8595
Email >
Follow us on
Visit website